Bahar Tercan

Dr. Bahar Tercan


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ALAsim Leblebici
Asim Leblebici
CSCeren Sancar
Ceren Sancar
BTBahar Tercan
Bahar Tercan
Zerrin IsikZerrin Isik
Zerrin Isik
Mehmet Emin ArayiciMehmet Emin Arayici
Mehmet Emin Arayici
NYNuri Yildirim
Nuri Yildirim
This paper aims to elucidate the differentially coexpressed genes, their potential mechanisms, and possible drug targets in low-grade invasive serous ovarian carcinoma (LGSC) in terms of the biologic continuity of normal, borderline, and malignant LGSC. We performed a bioinformatics analysis, integrating datasets generated using the GPL570 platform from different studies from the GEO database to identify changes in this transition, gene expression, drug targets, and their relationships with tumor microenvironmental characteristics. In the transition from ovarian epithelial cells to the serous borderline, the FGFR3 gene in the “Estrogen Response Late” pathway, the ITGB2 gene in the “Cell Adhesion Molecule”, the CD74 gene in the “Regulation of Cell Migration”, and the IGF1 gene in the “Xenobiotic Metabolism” pathway were upregulated in the transition from borderline to LGSC. The ERBB4 gene in “Proteoglycan in Cancer”, the AR gene in “Pathways in Cancer” and “Estrogen Response Early” pathways, were upregulated in the transition from ovarian epithelial cells to LGSC. In addition, SPP1 and ITGB2 genes were correlated with macrophage infiltration in the LGSC group. This research provides a valuable framework for the development of personalized therapeutic approaches in the context of LGSC, with the aim of improving patient outcomes and quality of life. Furthermore, the main goal of the current study is a preliminary study designed to generate in silico inferences, and it is also important to note that subsequent in vitro and in vivo studies will be necessary to confirm the results before considering these results as fully reliable.

18 March 2025 in STAR Protocols
Verified
Journal Article
Open access
BTBahar Tercan
Bahar Tercan
VAVictor H Apolonio
Victor H Apolonio
VCVinicius S Chagas
Vinicius S Chagas
CWChristopher K Wong
Christopher K Wong
JLJordan A Lee
Jordan A Lee
MCMauro Castro
Mauro Castro
As genes tend to be co-regulated as gene modules, feature selection in machine learning (ML) on gene expression data can be challenged by the complexity of gene regulation. Here, we present a protocol for reconciling differences in classifier features identified using different ML approaches. We describe steps for loading the PathwaySpace R package, preparing input for analysis, and creating density plots of gene sets. We then detail procedures for testing whether apparently distinct feature sets are related in pathway space. For complete details on the use and execution of this protocol, please refer to Ellrott et al.1.

17 November 2025
Verified
Book Chapter
Closed access
PDF file
NSNilus Swanson
Nilus Swanson
MCMauro A. A. Castro
Mauro A. A. Castro
ARA. Gordon Robertson
A. Gordon Robertson
ISIlya Shmulevich
Ilya Shmulevich
BTBahar Tercan
Bahar Tercan

4 April 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
NSNilus Swanson
Nilus Swanson
MCMauro A. A. Castro
Mauro A. A. Castro
ARA. Gordon Robertson
A. Gordon Robertson
ISIlya Shmulevich
Ilya Shmulevich
BTBahar Tercan
Bahar Tercan
Identifying MSI in whole slide images (WSIs), one of the most widely used diagnostic imaging formats, is of great importance and in demand. In this study we employed color-based texture features to predict MSI on both a tile and sample based level. We found that within cohorts of hematoxylin and eosin (H&E) stained WSIs, texture morphology is able to predict MSI on a tile level with an AUC of up to 0.95 and on a sample level with an AUC of up to 0.98. This runs in contrast to other methods for predicting MSI in H&E WSIs which either utilized artificial intelligence based models, or achieved lower accuracy scores. Our results demonstrate that texture morphology is a significantly notable factor when it comes to identifying MSI in H&E WSIs, and should be used when constructing future models for MSI identification in a clinical setting.